NADAC acquisition cost data for INSULIN GLARGINE SOLOSTAR U100. This is a generic medication, typically more affordable than brand-name equivalents.
| Generic Name | Insulin glargine-aglr |
| Brand Name | REZVOGLAR KWIKPEN |
| Manufacturer | A-S Medication Solutions |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Pharmacologic Class | Insulin Analog |
| Product Type | HUMAN PRESCRIPTION DRUG |
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 00955172805 | $10.87 | 2022-12-21 | Rx |
| 00955172805 | $10.87 | 2022-12-21 | Rx |
Generic: Insulin Glargine-Aglr | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | N/A | N/A | N/A | N/A |
| 2020 | N/A | N/A | N/A | N/A |
| 2021 | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A |
| 2023 | $66.7K | 838 | 421 | $6.26 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| Florida | $34.1K | 228 | 122 |
| Indiana | $8.7K | 272 | 115 |
| New York | $7.3K | 74 | 21 |
| Pennsylvania | $2.8K | 35 | 13 |
| Rhode Island | $2.2K | 30 | 19 |
| Michigan | $2.1K | 45 | 38 |
| California | $1.9K | 36 | N/A |
| New Jersey | $1.3K | 21 | 14 |
| North Carolina | $648.10 | 11 | N/A |
| Virginia | $262.50 | 11 | N/A |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.